In gastric cancer, the role of genomic alterations in PM development remains controversial: TCGA analyses revealed limited oncogenic pathway alterations in PM30, while Tanaka et al. reported enrichment of CDH1, SOX9, and EGFR in gastric PM versus primary tumors31. This evidence concerns the gene EGFR and gastric cancer.